FREE FORM DOCUMENT: CAN INCLUDE TEXT, HYPERLINKS, IMAGES AND EMBEDDED VIDEOS

The Information Source for the Pharmaceutical Manufacturing Industry

Welcome to Pharmaceutical Online, the premier sourcing site for the pharmaceutical manufacturing industry, find industry information on critical environment, particle sizing, pharma process control, pharma material handling, tablet production, pharma sterilizing, pharma cleaning, pharma filtration, pharma packaging, pharma inspection, & much more. Use our product showcase, and offline search service to expedite your discovery of new products and services. Our goal is to help buyers, like you, identify and select suppliers.

Pharmaceutical Online is part of the Life Science Connect media group. The vision of Life Science Leader and Life Science Connect is to help facilitate connections and foster collaborations in pharmaceutical and medical device development to find ways to get more life-saving and life-improving therapies to market. Connect, Collaborate, Contribute. Please take a moment to join our community and discover the benefits of your free membership.

IMAGE TITLE SUMMARY DISPLAY

  • Does Quality Even Matter? 10 Things Quality Departments Should Stop Doing Now
    Does Quality Even Matter? 10 Things Quality Departments Should Stop Doing Now

    Senior quality leaders and the FDA agree quality organizations supporting pharma manufacturing often fall short of providing the support necessary to maintain and increase regulatory compliance and product quality. At the same time, some do not understand their actions and believe they are obstructionist and reflective of a strict compliance mentality with little regard for the business and its success. What would cause business partners to look at quality in such a way?

  • 4 Strategies To Prevent Manufacture And Distribution Of Substandard Medications
    4 Strategies To Prevent Manufacture And Distribution Of Substandard Medications

    Counterfeit medications aren’t the only prescription drug-related threat to public health. If a legitimate product is not manufactured according to quality standards or becomes degraded as it travels through its supply chain, it can be ineffective at best or deadly at worst. However, separating the issues of counterfeit and substandard medications is a difficult proposition.

  • Are Regulatory Agencies Prepared For A Rapidly Aging Population?
    Are Regulatory Agencies Prepared For A Rapidly Aging Population?

    Despite changing demographics in aging populations, regulatory guidance specific to drug development for geriatrics has been limited, with guidances dating back to the 1990s.

More From Pharma Contributing Editors

TITLE SUMMARY DISPLAY

  • BioTrak Real-Time Viable Particle Counter Video

    Investigations of airborne viable excursions in cleanrooms using traditional techniques notoriously fail to identify a definitive root cause. What if this information were available in real-time when the contamination event occurred? This video introduces real-time viable particle monitoring and how it can quickly identify the source of a contamination.

  • Fast Track Serialization Solutions At Medochemie Ltd

    See the application of TQS Fast Track at a generic drug manufacturing company for their serialization, checkweighing and tamper-evident labelling requirements.

  • Thermo Fisher Scientific Suzhou, China Manufacturing Site Capabilities

    Watch this video to learn more about this manufacturing site capabilities, quality management systems, PPI implementation, product expansion, assurance of supply and lead times.

More From Pharmaceutical Online Videos

GRID WITH IMAGE DISPLAY

Does Quality Even Matter? 10 Things Quality Departments Should Stop Doing Now Does Quality Even Matter? 10 Things Quality Departments Should Stop Doing Now

Senior quality leaders and the FDA agree quality organizations supporting pharma manufacturing often fall short of providing the support necessary to maintain and increase regulatory compliance and product quality. At the same time, some do not understand their actions and believe they are obstructionist and reflective of a strict compliance mentality with little regard for the business and its success. What would cause business partners to look at quality in such a way?

4 Strategies To Prevent Manufacture And Distribution Of Substandard Medications 4 Strategies To Prevent Manufacture And Distribution Of Substandard Medications

Counterfeit medications aren’t the only prescription drug-related threat to public health. If a legitimate product is not manufactured according to quality standards or becomes degraded as it travels through its supply chain, it can be ineffective at best or deadly at worst. However, separating the issues of counterfeit and substandard medications is a difficult proposition.

Are Regulatory Agencies Prepared For A Rapidly Aging Population? Are Regulatory Agencies Prepared For A Rapidly Aging Population?

Despite changing demographics in aging populations, regulatory guidance specific to drug development for geriatrics has been limited, with guidances dating back to the 1990s.

Cybersecurity Among Biggest Challenges For Pharma Firms Incorporating Digital Health Technologies Cybersecurity Among Biggest Challenges For Pharma Firms Incorporating Digital Health Technologies

This is the second of two articles, this part focuses on the importance of cybersecurity and software maintenance, how time scales and methods of execution differ from those in traditional pharma, how agile software development works, and how to avoid potential pitfalls.

More From Pharma Contributing Editors

CONTACT INFORMATION

Pharmaceutical Online

5340 Fryling Road

Erie, PA 16510

UNITED STATES

Phone: 814-897-7700

TITLE SUMMARY DISPLAY

  • Does Quality Even Matter? 10 Things Quality Departments Should Stop Doing Now

    Senior quality leaders and the FDA agree quality organizations supporting pharma manufacturing often fall short of providing the support necessary to maintain and increase regulatory compliance and product quality. At the same time, some do not understand their actions and believe they are obstructionist and reflective of a strict compliance mentality with little regard for the business and its success. What would cause business partners to look at quality in such a way?

  • 4 Strategies To Prevent Manufacture And Distribution Of Substandard Medications

    Counterfeit medications aren’t the only prescription drug-related threat to public health. If a legitimate product is not manufactured according to quality standards or becomes degraded as it travels through its supply chain, it can be ineffective at best or deadly at worst. However, separating the issues of counterfeit and substandard medications is a difficult proposition.

  • Are Regulatory Agencies Prepared For A Rapidly Aging Population?

    Despite changing demographics in aging populations, regulatory guidance specific to drug development for geriatrics has been limited, with guidances dating back to the 1990s.

More From Pharma Contributing Editors

GRID WITH IMAGE DISPLAY

Does Quality Even Matter? 10 Things Quality Departments Should Stop Doing Now Does Quality Even Matter? 10 Things Quality Departments Should Stop Doing Now

Senior quality leaders and the FDA agree quality organizations supporting pharma manufacturing often fall short of providing the support necessary to maintain and increase regulatory compliance and product quality. At the same time, some do not understand their actions and believe they are obstructionist and reflective of a strict compliance mentality with little regard for the business and its success. What would cause business partners to look at quality in such a way?

4 Strategies To Prevent Manufacture And Distribution Of Substandard Medications 4 Strategies To Prevent Manufacture And Distribution Of Substandard Medications

Counterfeit medications aren’t the only prescription drug-related threat to public health. If a legitimate product is not manufactured according to quality standards or becomes degraded as it travels through its supply chain, it can be ineffective at best or deadly at worst. However, separating the issues of counterfeit and substandard medications is a difficult proposition.

Are Regulatory Agencies Prepared For A Rapidly Aging Population? Are Regulatory Agencies Prepared For A Rapidly Aging Population?

Despite changing demographics in aging populations, regulatory guidance specific to drug development for geriatrics has been limited, with guidances dating back to the 1990s.

More From Pharma Contributing Editors